Cancer remains one of the leading causes of death globally, with early diagnosis being critical to improving patient survival and treatment outcomes. The Cancer Diagnostics Market was valued at US$ 108,543.12 Million in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2032. This growth is fueled by increasing cancer prevalence, greater awareness about screening, and continuous...